PTCL success hinges on biomarker-aligned therapies, clear superiority, broad subtype reach, and scalable commercialization, supported by uptake, pricing, access, and competitive insights.Dublin, Oct.

Atherectomy is still the go-to treatment option for many clinicians, but p IVL appears to be gaining momentum as time goes on.

Peripheral vision is what you see beyond your direct line of sight. It helps provide a complete sense of your surroundings without moving your head. Jump to Key Takeaways. Within the eye, rods and ...

AI-personalized therapy, wireless and wearable innovation, portfolio expansion, partnerships, and localized supply chains offer key routes to stronger ROI and market reach.Dublin, Sept. 30, 2026 ...